Repligen Stock Pops After Covid Vaccines, Treatments Help Bolster 2020 Sales

Repligen Stock Pops After Covid Vaccines, Treatments Help Bolster 2020 Sales

Repligen handily beat fourth-quarter expectations on Wednesday, noting the push for Covid vaccines and treatments bolstered sales. In response, RGEN stock popped.